Jay Timmons, NAM CEO
Drug manufacturers are fighting mad about pricing legislation and they're taking the next round public
While drug pricing reform is snaking its way through Congress, the proposed legislation is facing some opposition from industry groups, as the National Association of …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.